Now that OPA has ramped up its audit activities, covered entities should not be surprised to find themselves on the receiving end of a 340B program review conducted by HRSA/OPA.  The likelihood of this may be increased if the entity uses contract pharmacies.  It is important therefore to be aware of what information is likely … Continue Reading